Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Net Margin (2020 - 2025)

Historic Net Margin for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to 95.15%.

  • Biofrontera's Net Margin fell 322400.0% to 95.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.28%, marking a year-over-year decrease of 109800.0%. This contributed to the annual value of 47.58% for FY2024, which is 115000.0% up from last year.
  • Per Biofrontera's latest filing, its Net Margin stood at 95.15% for Q3 2025, which was down 322400.0% from 58.96% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Net Margin registered a high of 57.03% during Q1 2022, and its lowest value of 369.45% during Q3 2021.
  • Its 5-year average for Net Margin is 74.61%, with a median of 62.53% in 2021.
  • In the last 5 years, Biofrontera's Net Margin tumbled by -2776600bps in 2021 and then skyrocketed by 3100800bps in 2022.
  • Over the past 5 years, Biofrontera's Net Margin (Quarter) stood at 158.21% in 2021, then soared by 83bps to 27.45% in 2022, then soared by 221bps to 33.28% in 2023, then tumbled by -133bps to 11.12% in 2024, then tumbled by -756bps to 95.15% in 2025.
  • Its Net Margin was 95.15% in Q3 2025, compared to 58.96% in Q2 2025 and 48.94% in Q1 2025.